A prediction model for xerostomia in locoregionally advanced nasopharyngeal carcinoma patients receiving radical radiotherapy

被引:6
|
作者
Li, Minying [1 ]
Zhang, Jingjing [1 ]
Zha, Yawen [1 ]
Li, Yani [1 ]
Hu, Bingshuang [1 ]
Zheng, Siming [1 ]
Zhou, Jiaxiong [1 ]
机构
[1] Zhongshan City Peoples Hosp, Dept Oncol Radiotherapy, 2 Sunwen Middle Rd, Zhongshan 528403, Guangdong, Peoples R China
关键词
Xerostomia; Nasopharyngeal carcinoma; Prediction; INTENSITY-MODULATED RADIOTHERAPY; QUALITY-OF-LIFE; NECK-CANCER-PATIENTS; RADIATION-THERAPY; HEAD; OUTCOMES; SALIVA; CHEMORADIATION; TOXICITY; PATTERNS;
D O I
10.1186/s12903-022-02269-0
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background This study was to evaluate the predictors of xerostomia and Grade 3 xerostomia in locoregionally advanced nasopharyngeal carcinoma (NPC) patients receiving radical radiotherapy and establish prediction models for xerostomia and Grade 3 xerostomia based on the predictors. Methods Totally, 365 patients with locoregionally advanced NPC who underwent radical radiotherapy were randomly divided into the training set (n = 255) and the testing set (n = 110) at a ratio of 7:3. All variables were included in the least absolute shrinkage and selection operator regression to screen out the potential predictors for xerostomia as well as the Grade 3 xerostomia in locoregionally advanced NPC patients receiving radical radiotherapy. The random forest (RF), a decision tree classifier (DTC), and extreme-gradient boosting (XGB) models were constructed. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), area under the curve (AUC) and accuracy were analyzed to evaluate the predictive performance of the models. Results In the RF model for predicting xerostomia, the sensitivity was 1.000 (95%CI 1.000-1.000), the PPV was 0.990 (95%CI 0.975-1.000), the NPV was 1.000 (95%CI 1.000-1.000), the AUC was 0.999 (95%CI 0.997-1.000) and the accuracy was 0.992 (95%CI 0.981-1.000) in the training set. The sensitivity was 0.933 (95%CI 0.880-0.985), the PPV was 0.933 (95%CI 0.880-0.985), and the AUC was 0.915 (95%CI 0.860-0.970) in the testing set. Hypertension, age, total radiotherapy dose, dose at 50% of the left parotid volume, mean dose to right parotid gland, mean dose to oral cavity, and course of induction chemotherapy were important variables associated with the risk of xerostomia in locoregionally advanced NPC patients receiving radical radiotherapy. The AUC of DTC model for predicting xerostomia was 0.769 (95%CI 0.666-0.872) in the testing set. The AUC of the XGB model for predicting xerostomia was 0.834 (0.753-0.916) in the testing set. The RF model showed the good predictive ability with the AUC of 0.986 (95%CI 0.972-1.000) in the training set, and 0.766 (95%CI 0.626-0.905) in the testing set for identifying patients who at high risk of Grade 3 xerostomia in those with high risk of xerostomia. Conclusions An RF model for predicting xerostomia in locoregionally advanced NPC patients receiving radical radiotherapy and an RF model for predicting Grade 3 xerostomia in those with high risk of xerostomia showed good predictive ability.
引用
下载
收藏
页数:13
相关论文
共 50 条
  • [1] A prediction model for xerostomia in locoregionally advanced nasopharyngeal carcinoma patients receiving radical radiotherapy
    Minying Li
    Jingjing Zhang
    Yawen Zha
    Yani Li
    Bingshuang Hu
    Siming Zheng
    Jiaxiong Zhou
    BMC Oral Health, 22
  • [2] Prognostic significance of wait time for radical radiotherapy in locoregionally advanced nasopharyngeal carcinoma
    Jiang, Yu-Ting
    Chen, Kai-Hua
    Yang, Jie
    Liang, Zhong-Guo
    Qu, Song
    Li, Ling
    Zhu, Xiao-Dong
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2022, 44 (05): : 1182 - 1191
  • [3] Optimizing induction chemotherapy regimens for radiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
    Li, Ying
    Bi, Jianping
    Pi, Guoliang
    He, Hanping
    Li, Yanping
    Zheng, Dandan
    Wei, Zecheng
    Han, Guang
    CANCER MEDICINE, 2023, 12 (08): : 9449 - 9457
  • [4] Predictors for improvement of xerostomia in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy
    Pan, Xin-Bin
    Liu, Yang
    Huang, Shi-Ting
    Chen, Kai-Hua
    Jiang, Yan-Ming
    Zhu, Xiao-Dong
    MEDICINE, 2019, 98 (36)
  • [5] Phase I clinical trial of nasopharyngeal radiotherapy and concurrent celecoxib for patients with locoregionally advanced nasopharyngeal carcinoma
    Xue, Wei-Ping
    Bai, Shou-Ming
    Luo, Ming
    Bi, Zhuo-Fei
    Liu, Yi-Ming
    Wu, Shao-Kun
    ORAL ONCOLOGY, 2011, 47 (08) : 753 - 757
  • [6] Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Locoregionally Advanced Nasopharyngeal Carcinoma
    Yu, Hong-Sheng
    Wang, Xin
    Song, Ai-Qin
    Liu, Ning
    Zhang, Wei
    Yu, Li
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (08) : 3961 - 3965
  • [7] Development of a Nomogram Model for Treatment of Elderly Patients with Locoregionally Advanced Nasopharyngeal Carcinoma
    Kou, Jia
    Zhang, Lu-Lu
    Yang, Xing-Li
    Wen, Dan-Wan
    Zhou, Guan-Qun
    Wu, Chen-Fei
    Xu, Si-Si
    Zheng, Wei-Hong
    Qi, Zhen-Yu
    Sun, Ying
    Lin, Li
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (11):
  • [8] Experience with combination of nimotuzumab and intensity-modulated radiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
    Zhai, Rui-ping
    Ying, Hong-mei
    Kong, Fang-fang
    Du, Cheng-run
    Huang, Shuang
    Zhou, Jun-jun
    Hu, Chao-su
    ONCOTARGETS AND THERAPY, 2015, 8 : 3383 - 3390
  • [9] Chemotherapy with or without radiotherapy in patients with locoregionally recurrent nasopharyngeal carcinoma
    Wong, ZW
    Tan, EH
    Yap, SP
    Tan, T
    Leong, SS
    Fong, KW
    Wee, J
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2002, 24 (06): : 549 - 554
  • [10] Radiation therapy for locoregionally advanced nasopharyngeal carcinoma in elderly patients
    Guo, Qiaojuan
    Jiang, Weiping
    Lin, Shaojun
    Yang, Ling
    Chen, Chuanben
    Xu, Luying
    Wu, Junxin
    Pan, Jianji
    JOURNAL OF RADIATION ONCOLOGY, 2012, 1 (04) : 323 - 332